REQUEST A DEMO
Total
USD $0.00
Search more companies

Societe De Therapeutique Marocaine Sa (Morocco)

Main Activities: Medicinal and Botanical Manufacturing
Full name: Societe De Therapeutique Marocaine Sa Profile Updated: March 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Sothema SA is a Morocco-based company specialized in the production and marketing of drugs, created on 26/01/1976 and the IPO dated on 21/02/2005. The Company provides drugs in the forms of tablets, capsules, syrups, ampoules, creams and ointments, as well as powders and suspensions for injections, among others. It exports the substantial share of its output to Europe, North and sub-Saharan Africa, among others, and it is also engaged in the manufacture of drugs under license and the importation of dental products. Sothema SA operates a subsidiary, West Afric Pharma, based in Senegal.

Headquarters
Bp N° 1, Zone Industrielle Bouskoura Casablanca
Bouskoura; Casablanca-Settat; Postal Code: 20180

Contact Details: Purchase the Societe De Therapeutique Marocaine Sa report to view the information.

Website: http://www.sothema.com

Basic Information
Total Employees:
Purchase the Societe De Therapeutique Marocaine Sa report to view the information.
Outstanding Shares:
Purchase the Societe De Therapeutique Marocaine Sa report to view the information.
Registered Capital:
Purchase the Societe De Therapeutique Marocaine Sa report to view the information.
Financial Auditors:
Purchase the Societe De Therapeutique Marocaine Sa report to view the information.
Incorporation Date:
1976
Key Executives
Purchase this report to view the information.
Chairperson
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Director / Member of the Management Board
Ownership Details
Purchase this report to view the information.
18.11%
Purchase this report to view the information.
9.81%
Purchase this report to view the information.
8.19%
Purchase this report to view the information.
7%
Purchase this report to view the information.
6.71%
Subsidiaries
Axess Pharma
100%
Leiden Pharma
100%
Tabid
95%
Company Performance
Financial values in the chart are available after Societe De Therapeutique Marocaine Sa report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MAD. Absolute financial data is included in the purchased report.
Net sales revenue
2.98%
Total operating revenue
2.32%
Operating profit (EBIT)
-16.27%
EBITDA
-14.63%
Net Profit (Loss) for the Period
-2.65%
Total assets
14.58%
Total equity
10.96%
Operating Profit Margin (ROS)
-4.03%
Net Profit Margin
-0.74%
Return on Equity (ROE)
-1.52%
Debt to Equity Ratio
12.01%
Quick Ratio
-0.04%
Cash Ratio
0.04%

Similar companies

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?